CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $137,000 | -28.6% | 11,300 | -16.9% | 0.06% | -33.3% |
| Q3 2019 | $192,000 | +43.3% | 13,600 | +12.9% | 0.08% | +44.8% |
| Q2 2019 | $134,000 | +3.1% | 12,046 | +9.1% | 0.06% | +3.6% |
| Q1 2019 | $130,000 | -47.6% | 11,046 | -40.5% | 0.06% | -67.1% |
| Q4 2018 | $248,000 | -87.2% | 18,574 | -86.6% | 0.17% | -74.9% |
| Q3 2018 | $1,940,000 | -9.9% | 138,374 | +1.1% | 0.68% | -13.6% |
| Q2 2018 | $2,152,000 | -4.3% | 136,874 | +0.1% | 0.78% | +1.6% |
| Q1 2018 | $2,249,000 | -10.4% | 136,696 | -1.6% | 0.77% | -17.4% |
| Q4 2017 | $2,509,000 | -12.7% | 138,946 | -6.7% | 0.94% | -21.4% |
| Q3 2017 | $2,875,000 | +62.4% | 148,946 | -0.7% | 1.19% | +49.4% |
| Q2 2017 | $1,770,000 | +7.3% | 149,996 | -0.3% | 0.80% | -4.9% |
| Q1 2017 | $1,649,000 | +51.0% | 150,496 | +0.0% | 0.84% | +47.5% |
| Q4 2016 | $1,092,000 | – | 150,422 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |